FDA Inspection
David P. Walling, Ph.D.David P. Walling, Ph.D. – FDA Inspection, Apr 16, 2014
Record Details
This FDA Inspection record concerns David P. Walling, Ph.D., with an inspection on April 16, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- David P. Walling, Ph.D.
- Inspection Date
- April 16, 2014
- Product Type
- Drugs
View Company Profile
ID · c979e17f-6b2d-41d7-bb8a-59f06ece08e4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 874815
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of David P. Walling, Ph.D.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| January 13, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 14, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 19, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 11, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 23, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for David P. Walling, Ph.D.
- FDA Inspection 1195349 - 2023-01-13
- FDA Inspection 1143823 - 2021-05-14
- FDA Inspection 1063079 - 2018-03-19
- FDA Inspection 917428 - 2015-03-11
- FDA Inspection 911140 - 2015-01-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.